← Back to All Filings

Organon & Co. Director Announces Plan to Not Seek Re-election in 2026

Low SignificanceNovember 7, 2025 at 7:31:45 AM EST

Organon & Co.

$OGN8-KCIK: 0001821825

Subscribe to track OGN

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Organon & Co. Director Announces Plan to Not Seek Re-election

Company: Organon & Co. (OGN) Form: 8-K | Filed: 2025-11-07 Significance: Low

Insider: Grace Puma Title: Director | Relationship: Director

Event: • Type: Director Departure Announcement • Effective: 2026 Annual Meeting

Key Insight: Director Grace Puma, a board member since 2021, will not stand for re-election at the 2026 annual meeting. The filing explicitly states the departure is not due to any disagreement with the company.

Market Context: This is a routine corporate governance event with a long lead time, suggesting a planned and orderly transition. No immediate market impact is expected.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Organon & Co. (OGN)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Director Grace Puma has announced she will not seek re-election at the 2026 Annual Meeting, signaling a routine and amicable board transition.
  • Market Impact: This event is not expected to have a material impact on the stock price.

Company Information

FieldValue
CompanyOrganon & Co.
Ticker SymbolOGN
CIK0001821825
IndustryPharmaceutical Preparations

Insider Information

FieldValue
NameGrace Puma
CIKnull
Title/PositionDirector
RelationshipDirector

Event Details

This Form 8-K filing details a corporate governance update rather than a financial transaction.

FieldValue
Form Type8-K
Event Date2025-11-03
DescriptionDirector Grace Puma informed the company she will not stand for re-election at the 2026 Annual Meeting.

Financial Impact Assessment

As this is a non-transactional corporate governance filing, there are no direct financial metrics to assess.

Impact Evaluation

  • Transaction Significance: The event is of low significance. The departure is planned for 2026, allowing for an orderly transition. The filing clarifies that the decision is not due to any disagreement with the company's operations, policies, or practices, which mitigates potential negative investor sentiment.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: A planned, amicable departure of a single board member is a routine event and is not considered material information that would influence investment decisions or the company's stock price.

Volume & Sentiment

  • Expected Volume Impact: No significant impact on trading volume is anticipated.
  • Sentiment Indicator: Neutral. The disclosure is procedural and lacks any controversial elements.

Additional Context

Event Notes

  • Timing: The announcement is made well in advance of the 2026 Annual Meeting, providing ample time for the board to manage the transition.
  • Special Circumstances: The filing explicitly states, "Ms. Puma’s departure is not due to any disagreement between her and the Company," which is a standard disclosure to prevent speculation.
Topics:#SECFiling#Form8K#OGN#Organon#CorporateGovernance#BoardOfDirectors#StockMarket#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.